LBO — EINSTEIN MEDICAL CENTER MONTGOMERY
IRR: 19.6% | MOIC: 2.45x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
19.6%
IRR
2.45x
MOIC
$195.5M
Entry EV
$330.7M
Exit EV
$100.6M
Equity Invested
Sources & Uses
S&UTotal · $195.5M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $75.9M | 38.8% | |
| Sub Debt | $19.0M | 9.7% | |
| Equity | $100.6M | 51.5% | |
| Enterprise Value | $189.8M | 97.1% | |
| Transaction Fees | $5.7M | 2.9% | |
| Total Uses | $195.5M | 100.0% |
Interpretation
INTAt 2.45x MOIC and 19.6% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $31.5M |
| Exit Ev | $330.7M |
| Net Debt At Exit | $84.5M |
| Equity At Exit | $246.2M |
| Equity Invested | $100.6M |
| Total Value Created | $145.6M |
| Value From Growth | $131.4M |
| Value From Multiple | $9.5M |
| Value From Deleveraging | $10.4M |